Q2 2023 · 13F-HR
Bill & Melinda Gates Foundationholdings as filed
Filed 2023-08-14 · accession 0000898432-23-000623
$125.6M
Reported value
9
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $38.2M | 30.4% | 1,559,142 | Common | SOLE |
| 45258D105 | IMCR | IMMUNCORE HLDGS PLC | $34.6M | 27.5% | 576,923 | Common | SOLE |
| N2451R105 | CVAC | CUREVAC N V | $16.9M | 13.5% | 1,625,943 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $16.0M | 12.8% | 148,674 | Common | SOLE |
| 30223G102 | EXAIEUR | EXSCIENTIA | $9.4M | 7.50% | 1,590,909 | Common | SOLE |
| G5709L109 | — | LUMIRADX LTD | $6.9M | 5.46% | 14,285,714 | Common | SOLE |
| 124155102 | BFLY | BUTTERFLY NETWORK INC | $2.3M | 1.85% | 1,011,003 | Common | SOLE |
| 04965G109 | BCELUSD | ATRECA INC | $913,179 | 0.73% | 931,815 | Common | SOLE |
| 03236M200 | — | AMYRIS INC | $301,170 | 0.24% | 292,398 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.